Swissmedic Launches UDI Module in swissdamed
Voluntary submissions begin in August 2025, with mandatory registration starting July 2026. The system aligns with EUDAMED standards, compliance, and post-market surveillance.
LEARN MORE
Switzerland Swissmedic/Swissdamed UDI Requirements & Compliance Resources
LEXISNEXIS LIFE SCIENCES SOLUTIONSUnderstanding UDI SeriesGain answers to your questions about Unique Device Identification (UDI). Book time with a UDI expert for in-depth Q&A plus access to a library of tutorials and reference materials
Swissdamed managed by Swissmedic
Switzerland has established its own medical device database, Swissdamed, managed by Swissmedic, to support national regulatory oversight following its transition away from direct participation in EU systems. Swissdamed is being implemented in phases, with mandatory use of the Product Module beginning July 1, 2026. This milestone will require manufacturers placing devices on the Swiss market to submit and maintain product data directly within the Swiss system, creating additional regulatory obligations for companies operating across Europe.
LexisNexis Life Sciences simplifies that complexity. We support manufacturers across the entire product lifecycle — from initial market entry and UDI data preparation to ongoing updates, change management, and post-market compliance. Our global regulatory expertise and technology-driven solutions help ensure your device data stays accurate, synchronized, and inspection-ready, so you can focus on innovation while we help safeguard compliance.
Need Guidance on UDI Compliance?
Understanding UDI obligations across global health authorities can be complex. Whether you are preparing for initial submission, managing product data updates, or aligning compliance across multiple markets, our regulatory experts provide practical guidance tailored to your organization’s needs.
Contact LexisNexis Life Sciences

Talk to a Life Sciences Regulatory Professional Today
Questions about medical device, pharmaceutical, or cosmetic products or services? We can help.
A LexisNexis regulatory expert will reach out soon.
A LexisNexis regulatory expert will reach out soon.
LexisNexis, a division of RELX Inc., may contact you in your professional capacity with information about our other products, services, and events that we believe may be of interest. You can manage your communication preferences via our Preference Center. You can learn more about how we handle your personal data and your rights by reviewing our Privacy Policy.
Reed Tech is now LexisNexis Life Sciences Solutions
While the Reed Tech name is being retired, the business has long operated as part of LexisNexis. Customers will continue to work with the same regulatory experts, services, and solutions—now unified within LexisNexis Life Sciences to reflect the broader capabilities and global resources of LexisNexis